Literature DB >> 29099463

Associations of Insulin Resistance and Glycemia With Liver Enzymes in Hispanic/Latino Youths: Results From the Hispanic Community Children's Health Study/Study of Latino Youth (SOL Youth).

Christina M Parrinello1, Bryan J Rudolph2, Mariana Lazo3, Linda C Gallo4, Bharat Thyagarajan5, Scott J Cotler6, Qibin Qi1, Tossaporn Seeherunvong7, Denise C Vidot8, Howard D Strickler1, Robert C Kaplan1, Carmen R Isasi1.   

Abstract

BACKGROUND: Associations of insulin resistance and hyperglycemia with a panel of liver enzymes have not been well studied in a young, heterogenous Hispanic/Latino population. We aimed to assess the associations of insulin resistance and glycemia with nonalcoholic fatty liver disease (NAFLD), as measured by liver enzymes and the pediatric NAFLD fibrosis index (PNFI), and whether these associations are modified by body mass index and mediated by inflammation or endothelial dysfunction.
MATERIALS AND METHODS: We conducted a cross-sectional study of 1317 boys and girls aged 8 to 16 years from the Hispanic Community Children's Health Study/Study of Latino Youth. We used Poisson regression to assess the associations of fasting glucose, hemoglobin A1c, and homeostasis model assessment of insulin resistance (HOMA-IR) with elevated alanine aminotransferase (ALT) (>25 U/L in boys, >22 U/L in girls), aspartate aminotransferase (AST) (≥37 U/L), gamma-glutamyl transpeptidase (GGT) (≥17 U/L), and PNFI (≥9; a function of age, waist circumference, and triglyceride level).
RESULTS: HOMA-IR was associated with elevated ALT, AST, GGT, and PNFI [prevalence ratios (95% confidence intervals) for each 1-unit increase in the natural log of HOMA-IR: 1.99 (1.40-2.81), 2.15 (1.12-4.12), 1.70 (1.26-2.30), and 1.98 (1.43-2.74), respectively]. Associations were observed in overweight/obese children, but not in normal weight children (P-interaction=0.04 for AST and P-interaction=0.07 for GGT). After further adjustment for adiponectin, high-sensitivity C-reactive protein, e-selectin, and PAI-1, associations of HOMA-IR with liver enzymes and PNFI were attenuated, but remained statistically significant for AST and PNFI.
CONCLUSION: Insulin resistance was associated with NAFLD in overweight/obese Hispanic/Latino youth, and this association may be partially mediated by inflammation and endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29099463      PMCID: PMC5934331          DOI: 10.1097/MCG.0000000000000946

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  44 in total

Review 1.  Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?

Authors:  Luca Valenti; Elisabetta Bugianesi; Utpal Pajvani; Giovanni Targher
Journal:  Liver Int       Date:  2016-06-30       Impact factor: 5.828

2.  Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.

Authors:  Salvatore Calanna; Roberto Scicali; Antonino Di Pino; Filip Krag Knop; Salvatore Piro; Agata Maria Rabuazzo; Francesco Purrello
Journal:  Acta Diabetol       Date:  2014-01-18       Impact factor: 4.280

3.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

Authors:  J H Warram; B C Martin; A S Krolewski; J S Soeldner; C R Kahn
Journal:  Ann Intern Med       Date:  1990-12-15       Impact factor: 25.391

Review 4.  Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance.

Authors:  Mohamed Asrih; François R Jornayvaz
Journal:  J Endocrinol       Date:  2013-08-28       Impact factor: 4.286

5.  New evidence for an association between liver enzymes and pancreatic islet β-cell dysfunction in young obese patients.

Authors:  Li Wang; Juanjuan Zhang; Bokai Wang; Yuwen Zhang; Jie Hong; Yifei Zhang; Weiqing Wang; Weiqiong Gu
Journal:  Endocrine       Date:  2013-04-03       Impact factor: 3.633

Review 6.  Review: The role of insulin resistance in nonalcoholic fatty liver disease.

Authors:  Kristina M Utzschneider; Steven E Kahn
Journal:  J Clin Endocrinol Metab       Date:  2006-09-12       Impact factor: 5.958

7.  Increased liver markers are associated with higher risk of type 2 diabetes.

Authors:  Sun-Hye Ko; Myong Ki Baeg; Kyung-Do Han; Seung-Hyun Ko; Yu-Bae Ahn
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

8.  2000 CDC Growth Charts for the United States: methods and development.

Authors:  Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson
Journal:  Vital Health Stat 11       Date:  2002-05

9.  Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A L C Schneider; M Lazo; C E Ndumele; J S Pankow; J Coresh; J M Clark; E Selvin
Journal:  Diabet Med       Date:  2013-04-12       Impact factor: 4.359

10.  Prevalence of diabetes among Hispanics/Latinos from diverse backgrounds: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Authors:  Neil Schneiderman; Maria Llabre; Catherine C Cowie; Janice Barnhart; Mercedes Carnethon; Linda C Gallo; Aida L Giachello; Gerardo Heiss; Robert C Kaplan; Lisa M LaVange; Yanping Teng; Leonel Villa-Caballero; M Larissa Avilés-Santa
Journal:  Diabetes Care       Date:  2014-08       Impact factor: 19.112

View more
  2 in total

1.  Socioeconomic Adversity, Social Resources, and Allostatic Load Among Hispanic/Latino Youth: The Study of Latino Youth.

Authors:  Linda C Gallo; Scott C Roesch; Julia I Bravin; Kimberly L Savin; Krista M Perreira; Mercedes R Carnethon; Alan M Delamater; Christian R Salazar; Maria Lopez-Gurrola; Carmen R Isasi
Journal:  Psychosom Med       Date:  2019-04       Impact factor: 4.312

2.  Associations of sleep duration and social jetlag with cardiometabolic risk factors in the study of Latino youth.

Authors:  Dayna A Johnson; Michelle Reid; Thanh-Huyen T Vu; Linda C Gallo; Martha L Daviglus; Carmen R Isasi; Susan Redline; Mercedes Carnethon
Journal:  Sleep Health       Date:  2020-04-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.